Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of de Novo Fanconi Anemia Patients Using FANCD2 Western Blots

NCT01146210 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01146210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01146210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of de Novo Fanconi Anemia Patients Using FANCD2 Western Blots
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
May 31, 2009
Completion date
May 31, 2016
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

childhood acute erythroleukemia (m6), childhood acute megakaryocytic leukemia (m7), childhood acute minimally differentiated myeloid leukemia (m0), childhood acute monoblastic leukemia (m5a), childhood acute monocytic leukemia (m5b), childhood acute myeloblastic leukemia with maturation (m2), childhood acute myeloblastic leukemia without maturation (m1), childhood acute myelomonocytic leukemia (m4), childhood myelodysplastic syndromes, chronic myelomonocytic leukemia, de novo myelodysplastic syndromes, fanconi anemia, refractory anemia, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, refractory anemia with ringed sideroblasts, secondary myelodysplastic syndromes, untreated childhood acute myeloid leukemia and other myeloid malignancies